1. Agid Y, Bonnet AM, Pollak P, Signoret JL, Lhermitte F (1979) Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson’s disease. Lancet 1: 570–572
2. Agid Y, Quinn N, Lhermitte F (1981) Long-term results of treatment of Parkinson’s disease with bromocriptine and domperidone. Rev Neurol 137: 49–51
3. Bainbridge CW, Heistad DD (1980) Effect of haloperidol on ventilatory responses to dopamine in man. J Pharmacol Exp Ther 213: 13–17
4. Barbeau A, Mars H, Gillo-Joffroy L (1971) Adverse clinical side-effects of levodopa therapy. In: Me Dowell, Markham CH (eds) Recent advances in Parkinson’s disease. Davis, Philadelphia, pp 204–237
5. Bateman DN, Davies DS (1979) Pharmacokinetics of metoclopramide. Lancet 1: 166